信邦制药: 半年报监事会决议公告

Meeting Details - The ninth supervisory board's eighth meeting of Guizhou Xinbang Pharmaceutical Co., Ltd. was held on August 28, 2025, in Guiyang, combining in-person and remote participation [1] - The meeting was legally convened with all three supervisors present, including one participating via remote communication [1] Meeting Resolutions - The supervisory board reviewed and approved the procedures for the preparation and review of the 2025 semi-annual report and its summary, confirming compliance with legal and regulatory requirements, and asserting that the report accurately reflects the company's actual situation without any false statements or omissions [1] - The board unanimously agreed (3 votes in favor, 0 against, 0 abstentions) on the 2025 semi-annual profit distribution plan, which aligns with relevant regulations and the company's profit distribution policy, ensuring no harm to shareholders, particularly minority shareholders [2] - The profit distribution plan will be submitted for approval at the company's first extraordinary general meeting of shareholders in 2025 [2]